Skip to main content

Eddy Jodi Euerle's Form 4 filing

Boston Scientific Corp (BSX) · filed Aug 4, 2021

Accession no.
0001225208-21-011117
Filed
Aug 4, 2021
Trade date
Aug 2-3, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $33.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Eddy Jodi EuerleCIK 0001734900Officer (SVP, Chief Info & Digital Off.)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockSSaleDisposed−727$45.77−$33,274.7920,050Direct
Aug 3, 2021Common StockMOption exerciseAcquired+1,973$0.00F2$022,023Direct
Aug 3, 2021Common StockFTax withholdingDisposed−876$45.54−$39,893.0421,147Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2021Common StockMOption exerciseDisposed−1,973$0.00$05,921Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)